Table 2.
Proportions of AIDS or Death at 48 weeks
Study Population |
Immediate ART Arm |
Early ART Arm |
|||
---|---|---|---|---|---|
N | Proportion with AIDS or death by 48 weeks |
95% CI for Difference in Proportions |
P Value | ||
All Patients | 806 | 12.9% | 16.1% | (−1.8%, 8.1%) | 0.45* |
Within CD4 Stratum: | |||||
< 50 cells/mm3 | 285 | 15.5% | 26.6% | (1.5%, 20.5%) | 0.02 |
≥ 50 cells/mm3 | 521 | 11.5% | 10.3% | (−6.7%, 4.3%) | 0.67 |
Subsets: | |||||
Confirmed TB at Entry | 374 | 13.8% | 19.7% | (−1.8%, 13.6%) | 0.21* |
Within CD4 Stratum: | |||||
< 50 cells/mm3 | 151 | 17.9% | 31.4% | (−0.4%, 27.3%) | 0.06 |
≥ 50 cells/mm3 | 223 | 10.8% | 12.1% | (−7.3%, 9.8%) | 0.77 |
Suspected TB at Entry | 432 | 15.4% | 19.7% | (−3.0%, 11.7%) | 0.35* |
Within CD4 Stratum: | |||||
< 50 cells/mm3 | 134 | 14.1% | 30.5% | (2.5%, 30.4%) | 0.02 |
≥ 50 cells/mm3 | 298 | 15.9% | 14.5% | (−9.8%, 7.1%) | 0.75 |
Low BMI (≤18.5 kg/m2) at Entry | 332 | 16.3% | 26.5% | (1.2%, 19.2%) | 0.06* |
Within CD4 Stratum: | |||||
< 50 cells/mm3 | 130 | 15.2% | 38.2% | (8.0%, 37.8%) | 0.003 |
≥ 50 cells/mm3 | 202 | 16.9% | 17.8% | (−9.9%, 11.6%) | 0.88 |
Stratified by CD4 stratum